-
Immune Pharmaceuticals Appoints Ranch C. Kimball as Chairman of the Board of Directors
Post on 1/29/17
-
Is GlaxoSmithKline's Dividend Sustainable?
Post on 1/27/17
-
5 Things You Need to Know From Bristol-Myers Squibb's Q4 Update
Post on 1/27/17
-
Quest Diagnostics Partners With Montefiore Health System
Post on 1/26/17
-
Enteris BioPharma Enters into Agreement with Nordic Bioscience's KeyBioscience
Post on 1/25/17
-
SOTA Medical Products and SafeOp Surgical Ink Distribution Agreement
Post on 1/25/17
-
American Health Council Names Luay Susan, M.D., to Physician Board
Post on 1/25/17
-
Aptuit Announces Drug Discovery Collaboration with Massachusetts General Hospital
Post on 1/24/17
-
Immunomedics Mails Letter to Stockholders
Post on 1/24/17
-
I'm Buying Bristol-Myers Squibb Here At 52-Week Lows
Post on 1/24/17
-
Enteris BioPharma Enters Agreement with Sanofi
Post on 1/23/17
-
Blink Fitness Announces Expansion Throughout Philadelphia
Post on 1/23/17
-
Aptuit Announces Drug Discovery Collaboration with Massachusetts General Hospital
Post on 1/23/17
-
This Little Biotech Could Have a Big Winner on Its Hands
Post on 1/23/17
-
How Will Pfizer Inc. Fare Under President Trump?
Post on 1/23/17
-
Better Buy: Merck & Co. Inc. vs. Pfizer
Post on 1/23/17
-
Top Biotech Stocks to Buy in 2017
Post on 1/23/17
-
Should You Be Afraid of Huge Medicare Changes Under President Trump?
Post on 1/23/17
-
3 Biotechs Likely to Be Acquired in 2017
Post on 1/23/17
-
Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and License Agreement with Merck
Post on 1/22/17
-
Stemline Therapeutics Prices $45 Million Public Offering of Common Stock
Post on 1/20/17
-
Schweiger Dermatology Group Opens New Office in Great Neck, New York
Post on 1/18/17
-
The Grand Healthcare System Completes Acquisition of River Valley Care Center
Post on 1/18/17
-
Better Buy: Amgen Inc. vs. Celgene Corporation
Post on 1/18/17
-
Should Pfizer, Inc. Be on Your Stock Watchlist?
Post on 1/18/17
New York
